Skip to main content
Article thumbnail
Location of Repository

Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study

By F Hanisch, M Wendt and S Zierz
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2008). An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology
  2. (2008). Group. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology
  3. (2003). Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study.
  4. (2001). Mycophenolate mofetil in the therapy of severe myasthenia gravis. Eur Neurol
  5. (2001). Preliminary results of an open label trial of cellcept in myasthenia gravis. Neurology
  6. (2005). Promary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. Neurology
  7. (1998). Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil. Neurology

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.